Norwich Pharmaceuticals

Norwich Pharmaceuticals, Inc. is expanding its development services offerings through a selective buildup of technical personnel and capital investments in specialized equipment. As part of this initiative, Carolyn A. Gherardi has been named vice president, Technology & Development Services (TDS). Mrs. Gherardi will be the principal point of contact for the company’s added capabilities.

Mrs. Gherardi most recently served as vice president of operations at Norwich for the past three years. Prior to joining the company, she held numerous positions with P&G Pharmaceuticals, covering all phases of the pharmaceutical manufacturing process.

According to Mrs. Gherardi, “As our company motto clearly states, we have always strived to provide our clients with uncommon value and everyday excellence. Through this expansion of our Technology & Development Services, we will be adding substantially to the ‘uncommon value’ portion of that equation — offering full service product development support from formulation through commercial product optimization, as well as individual services in many specialized areas.”
 
Also, Shailesh B. Shah, MS, RPH has been appointed vice president, R&D. Mr. Shah joins the company from Par Pharmaceuticals and has 25 years of experience developing formulations of immediate release and controlled release solid oral products from concept to market introduction.

Norwich previously focused its services primarily on commercial manufacturing and packaging, but the company is now undertaking development and optimization projects for several customers. The company plans to apply this experience to assist customers throughout the life cycle of a product, as well as plan and launch new initiatives from line extensions to explorations into new product categories.